top
logo

Connection



Partners

In Partnership with

In Partnership with the Society of Interventional Radiology
logo_avir
Endovascular.org : The Endovascular Forum


Home Discover the Latest on HCC at GEST 2010 San Francisco
Discover the Latest on HCC at GEST 2010 San Francisco
liver4 March 2010 - Do you want to learn more about the latest developments in treatment of HCC? The Global Embolization Symposium and Technologies (GEST) 2010 meeting in San Francisco will deliver a truly global review of state of the art of treatment of HCC from world leaders in the field of Interventional oncology.


Sessions and international faculty from the GEST 2010 Plenary Session on HCC held Saturday 8 May include:

  • Review of vascular anatomy collateral and variants and micro-circulation, Osamu Matsui, JP
  • New imaging technology in HCC: fusion imaging, flat panel CT, Daniel Sze, US
  • When do we need biopsy? Evidence and guidelines, Matthew Johnson, US
  • Hypovascular tumor: how to find your way? Shiro Miyayama, JP
  • HCC supplied by extrahepatic collaterals: how to treat, Jin Wook Chung, KS
  • Arterio portal shunting: how to treat, Kyoichiro Yamakado, JP
  • Technical differences and endpoints between TACE and DE beads, Thierry De Baere, FR
  • Synergies between loco-regional and systemic treatments in HCC , Riccardo Lencioni, IT
  • Loco-regional therapy of liver tumors: Rf, Microwave, etc., Riccardo Lencioni, IT

 

Sessions and international faculty from the GEST 2010 Plenary Session on Liver Tumor held Saturday 8 May include:

  • Imaging for assessment of tumor viability after therapy, Riad Salem, US
  • Is there a role for percutaneous hepatic perfusion? Frederick Moeslein, US
  • State of evidence: TACE, Daniel Sze, US
  • State of evidence: drug eluting beads, Jeff F Geschwind, US
  • State of evidence: bland embolization, Franco Orsi, IT
  • State of evidence: combined therapy Kyoichiro Yamakado, JP
  • Portal vein embolization: basic review of procedural steps, Dong Il Gwon, KS
  • Portal vein embolization: material selection and results, Masahide Takahashi, JP
  • Neuroendocrine tumors: bland embolization, TACE or radioembolization, Thierry de Baere, FR

 

Sessions and international faculty from the GEST 2010 Plenary Session on Radioembolization held Friday 7 May include:

  • Start-up essentials: finding partners, assembling a team, Riad Salem, US
  • Becoming an authorized user, where and how it is possible, Matthew Johnson, US
  • Radioembolization: practice building, cost and reimbursement issues, Daniel Brown, US
  • Patient selection work-up and dose calculation, Daniel Brown, US
  • Radioembolization: review of dangerous arterial anatomy, Thomas Kroencke, DE
  • Radioembolization: state of the evidence in hepatic metastases, William Rilling, US
  • Radioembolization: state of the evidence in HCC and cholangiocarcinoma, John Kaufman, US
  • Radioembolization: complications, Riad Salem, US
  • Radioembolization in neuroendocrine tumors, William Rilling, US

 

For more up-to-date information about GEST 2010 scientific sessions and faculty, including an online program, please visit www.gest2010.org. GEST 2010 conference will be held at the San Francisco Westin Market Street Hotel from the 6-9 May 2010.

Attending next week’s Society of Interventional Radiology (SIR) meeting in Tampa, Florida? Stop by and visit our stand for more information about GEST 2010.

We look forward to your participation at GEST 2010,

Directors

 

bottom

GEST C/O OVERCOME
3-5 bld Paul Emile Victor
Neuilly Sur Seine Cedex 92523 France
Tel: +33 1 40 88 97 94
Fax: +33 1 40 88 97 90
Email:
info@gestweb.org